Skip to main content
. Author manuscript; available in PMC: 2019 Jul 27.
Published in final edited form as: Int J Tuberc Lung Dis. 2016 May;20(5):582–587. doi: 10.5588/ijtld.15.0807

Table 4.

Antibiotics received during follow-up (n = 90)*

Antibiotic n (%)
Azithromycin/clarithromycin 87 (97)
Ethambutol 54 (60)
Rifampin/rifabutin 42 (47)
Moxifloxacin 42 (47)
Linezolid 36 (40)
Amikacin (intravenous or inhaled) 28 (31)
Meropenem 17 (19)
Clofazimine 13 (14)
Ciprofloxacin 12 (13)
Tigecycline 4 (4.4)
Levofloxacin 2 (2.2)
Imipenem 1 (1.1)
*

Only included for antibiotics given for at least 3 months; complete antibiotic information was missing for 16 patients.